Ozempic (semaglutide) is a once-weekly injection that lowers blood sugar in people with type 2 diabetes by mimicking a natural gut hormone called GLP-1. In clinical trials, it reduced HbA1c by 1.5% to 1.8% over 30 to 56 weeks. But blood sugar control is only part of the story: the drug also promotes weight loss, protects the heart, and slows kidney disease progression, which is why it has become one of the most widely prescribed diabetes medications available.
How Ozempic Lowers Blood Sugar
After you eat, your gut naturally releases a hormone called GLP-1. Semaglutide is a lab-modified version of that hormone, designed to last much longer in your body. When it binds to GLP-1 receptors on your pancreas, two things happen simultaneously: your insulin-producing beta cells release more insulin, and your glucagon-producing alpha cells dial back glucagon, a hormone that tells your liver to dump sugar into your bloodstream. The net effect is lower blood sugar after meals and throughout the day.
What makes this mechanism particularly useful is that it’s glucose-dependent. The drug ramps up insulin secretion when blood sugar is high and backs off when it’s normal, which means the risk of dangerously low blood sugar (hypoglycemia) is much lower than with older diabetes drugs like sulfonylureas or insulin itself.
Effects on Appetite and Weight
Ozempic works on the brain as well as the pancreas. GLP-1 receptors in the hypothalamus, the brain’s appetite control center, respond to semaglutide by increasing feelings of fullness. At the same time, the drug slows the rate at which food leaves your stomach. Together, these effects mean you feel satisfied sooner and stay full longer, which naturally reduces how much you eat.
For people with type 2 diabetes, the weight loss is meaningful but more modest than the numbers you may have seen in headlines about obesity treatment. In studies, diabetes patients lost roughly 9.6% of their body weight over 68 weeks. People with milder, earlier-stage diabetes tended to lose more (around 8.3% at 12 months), while those with more advanced disease lost less (about 5.5%). This weight loss matters beyond appearance. Losing even 5% of body weight improves insulin sensitivity, blood pressure, and cholesterol.
Cardiovascular Protection
Heart disease is the leading cause of death in people with type 2 diabetes, and Ozempic has proven benefits here. Across the SUSTAIN 6 and PIONEER 6 trials, semaglutide reduced major cardiovascular events (heart attack, stroke, or cardiovascular death) by 24% compared to placebo over a median follow-up period. The strongest effect was on non-fatal stroke, where risk dropped by 35%.
These results are significant enough that the American Diabetes Association’s 2025 guidelines now recommend GLP-1 receptor agonists like semaglutide for any adult with type 2 diabetes who has established heart disease or is at high risk for it, regardless of their current blood sugar levels. In other words, the cardiovascular protection alone can justify using the drug even if your HbA1c is already at target.
Kidney Disease Benefits
Diabetes is the most common cause of chronic kidney disease, and the FLOW trial, a large study focused specifically on kidney outcomes, showed that semaglutide reduced the risk of major kidney events by 24% over a median of 3.4 years. That composite included kidney failure, severe drops in kidney function, and death from kidney or cardiovascular causes.
Current ADA guidelines recommend GLP-1 receptor agonists for people with type 2 diabetes and chronic kidney disease, particularly when kidney function has declined significantly. For those with advanced kidney disease (very low filtration rates), semaglutide is actually preferred over several other diabetes medications because it carries a lower risk of hypoglycemia.
Who Should Not Take Ozempic
Ozempic carries an FDA boxed warning related to thyroid tumors. In animal studies, semaglutide caused a specific type of thyroid cancer called medullary thyroid carcinoma. It’s not confirmed whether this risk applies to humans, but the drug is contraindicated if you or a close family member has a history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. It’s also not an option for anyone who has had a serious allergic reaction to semaglutide.
Ozempic is approved for type 2 diabetes only. It is not used for type 1 diabetes, where the pancreas produces little or no insulin, because the drug works by enhancing insulin release from existing beta cells.
How the Dosing Schedule Works
Ozempic is injected once a week using a prefilled pen, on the same day each week. You can inject it in your abdomen, thigh, or upper arm, and it doesn’t need to be taken with food. The dosing follows a gradual ramp-up schedule designed to minimize side effects, particularly nausea.
- Weeks 1 through 4: 0.25 mg weekly. This is not a therapeutic dose. It’s purely to let your body adjust.
- Weeks 5 and beyond: Your dose increases to 0.5 mg, then potentially to 1 mg, and up to a maximum of 2 mg weekly, depending on how well your blood sugar responds and how you tolerate the medication.
Each step up typically lasts at least four weeks. Your provider will decide how high to go based on your blood sugar numbers and any side effects you experience. Many people find their optimal dose at 0.5 mg or 1 mg and never need the maximum.
Common Side Effects
The most frequent side effects are gastrointestinal: nausea, vomiting, diarrhea, abdominal pain, and constipation. These tend to be worst during the first few weeks at each new dose level and typically improve as your body adjusts. The slow dose escalation schedule exists specifically to reduce these effects. Eating smaller meals and avoiding high-fat or greasy foods can also help.
The delayed gastric emptying that helps control appetite can occasionally become a problem. If food sits in your stomach too long, it can cause significant nausea or bloating. This is worth mentioning to your provider if it persists, especially before any procedure that requires an empty stomach, like surgery or certain imaging tests.
Where Ozempic Fits in Diabetes Treatment
For most people with type 2 diabetes, metformin remains the first medication prescribed. Ozempic is often added when metformin alone isn’t keeping blood sugar in range, or it may be recommended early on if you have heart disease, kidney disease, or a high body weight. The 2025 ADA guidelines also recommend GLP-1 receptor agonists for people with type 2 diabetes who have fatty liver disease or heart failure with preserved ejection fraction, reflecting the drug’s benefits well beyond blood sugar.
Ozempic can be used alongside metformin, certain other oral diabetes medications, and even insulin, though combining it with insulin or drugs that stimulate insulin release may require dose adjustments to avoid low blood sugar. It is not a substitute for insulin in people who need it, but for many with type 2 diabetes, it can delay or reduce the need for insulin therapy by improving the body’s own insulin response.